Dabigatran and left atrial appendage thrombus
- 27 May 2012
- journal article
- case report
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 34 (4) , 545-547
Abstract
A 59-year-old white woman with previous history of arterial hypertension consulted because of palpitations. Atrial fibrillation of uncertain duration was diagnosed. She was not receiving anticoagulants. A trans-esophageal echocardiogram was performed, and a large left atrial appendage thrombus was detected. A strategy of rate control and anti-vitamin K treatment was started. On the subsequent days, we could not reach therapeutic INRs. Therefore, it was decided to stop warfarin and initiate dabigatran. We describe the evolution of the patient, the thrombus resolution, and a successful electrical cardioversion. In our comments, we summarize the natural history of left atrial thrombus, both with and without anticoagulant therapy. We also discuss the differences between warfarin and dabigatran.Keywords
This publication has 20 references indexed in Scilit:
- The CHADS2 versus the New CHA2DS2‐VASc Scoring Systems for Guiding Antithrombotic Treatment of Patients with Atrial Fibrillation: Review of the Literature and Recommendations for UsePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012
- New Frontiers for Stroke Prevention in Atrial FibrillationCerebrovascular Diseases, 2012
- Prevention of Cardioembolic StrokeNeurotherapeutics, 2011
- Stroke Risk and Antithrombotic Strategies in Atrial FibrillationStroke, 2010
- Stroke in atrial fibrillation: Update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devicesAnnals of Medicine, 2007
- Utility of Transesophageal Echocardiography in Identification of Thrombogenic Milieu in Patients With Atrial Fibrillation (an ACUTE Ancillary Study)The American Journal of Cardiology, 2005
- Direct Thrombin InhibitorsNew England Journal of Medicine, 2005
- Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversionEuropean Heart Journal, 2000
- Synthetic Inhibitors of Thrombin and Factor XaThrombosis Research, 1999
- The Regulation of Hemostasis: The Protein C SystemNew England Journal of Medicine, 1986